Global Endometrial Ablation Devices Market Overview:
The endometrial ablation devices market is expected to grow in the future due to an increasing awareness related to the advanced technology in the device and high preference from several medical practitioners. Endometrial ablation devices are used for the treatment of menorrhagia due to dysfunctional uterine bleeding. Global generation endometrial devices provide patients with less invasive surgical alternatives to hysterectomy, once childbearing is complete. Apart from the advantages of the devices, the factors driving the segment growth are the increasing prevalence of cervical cancer, menorrhagia, and other gynecology disorders.
- Increasing Incidence of Gynecological Disorders and Endometrial Cancer in Women
- High Number of Menorrhagia Affected Population
- Technological Advancements in the Ablation Procedures
- High Cost Associated with Ablation Procedures
- Increasing Awareness about the Endometrial Ablation Devices
- Rising Healthcare Expenditure in Developing Countries
- High Growth Prospects in Emerging Markets
- Stringent Regulatory Procedures Requirements for Approval of Devices
The global Endometrial Ablation Devices market including many local as well as regional players. Leading global players are focusing on strategic partnerships to improve their products and services. In addition, companies are focusing on increasing their client base to strengthen market position and to enhance product & service offerings.
Some of the key players profiled in the report are Boston Scientific (United States), Medtronic (United States), Johnson & Johnson (United States), Hologic, Inc (United States), St. Jude Medical (United States), Smith & Nephew plc (United Kingdom), KARLSTORZ GmbH & Co (Germany), Cooper Surgical (United States), Minerva Surgical (United States), CONMED Corporation (United States), AngioDynamics (United States) and AtriCure (United States). Additionally, following companies can also be profiled that are part of our coverage like Richard Wolf GmbH (Germany) and Olympus Corporation (Japan). Analyst at AMA Research see United States Players to retain maximum share of Global Endometrial Ablation Devices market by 2026. Considering Market by End User, the sub-segment i.e. Ambulatory Surgery Center will boost the Endometrial Ablation Devices market.
Latest Market Insights:
In May 2020, Minerva Surgical announced the closing of the acquisition of Boston Scientific's Intrauterine Health franchise. Minerva's combined product line will provide healthcare practitioners with the most complete and trusted product portfolio for treating Abnormal Uterine Bleeding (AUB). According to the American College of Obstetricians and Gynecologists, about one-third of women seek treatment for heavy menstrual bleeding.
In 2017, Hologic, Inc. announced the launch of its next-generation NovaSure® ADVANCED global endometrial ablation (GEA) system in the United States. The system has been FDA approved.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Endometrial Ablation Devices market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Endometrial Ablation Devices market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Manufacturers of Endometrial Ablation Devices, Suppliers of Endometrial Ablation Devices, Wholesalers, Distributors and Retailers of Endometrial Ablation Devices, Healthcare Industry, Government Regulators, Clinical Laboratory and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.